• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hydroxycarbamide for very young children with sickle cell anaemia: no effect on the primary outcomes of spleen or kidney function, but evidence for decreased pain and dactylitis, with minimal toxicity.

作者信息

Manwani Deepa

机构信息

Department of Pediatrics, Albert Einstein College of Medicine, Children's Hospital at Montefiore, Bronx, New York 10467, USA.

出版信息

Evid Based Med. 2012 Apr;17(2):37-8. doi: 10.1136/ebm.2011.100104. Epub 2011 Sep 3.

DOI:10.1136/ebm.2011.100104
PMID:21891796
Abstract
摘要

相似文献

1
Hydroxycarbamide for very young children with sickle cell anaemia: no effect on the primary outcomes of spleen or kidney function, but evidence for decreased pain and dactylitis, with minimal toxicity.羟基脲用于镰状细胞贫血幼儿：对脾脏或肾脏功能的主要结局无影响，但有证据表明疼痛和指（趾）炎减轻，且毒性极小。
Evid Based Med. 2012 Apr;17(2):37-8. doi: 10.1136/ebm.2011.100104. Epub 2011 Sep 3.
2
Early onset dactylitis associated with the occurrence of severe events in children with sickle cell anaemia. The Paediatric Cohort of Guadeloupe (1984-99).早发性手指炎与镰状细胞贫血患儿严重事件的发生。瓜德罗普岛儿科队列研究（1984 - 1999年）。
Paediatr Perinat Epidemiol. 2006 Jan;20(1):59-66. doi: 10.1111/j.1365-3016.2006.00692.x.
3
The safety and efficacy of hydroxycarbamide in infants with sickle cell anemia.羟基脲治疗镰状细胞贫血婴儿的安全性和有效性。
Expert Rev Hematol. 2011 Aug;4(4):407-9. doi: 10.1586/ehm.11.40.
4
Phase I study of magnesium pidolate in combination with hydroxycarbamide for children with sickle cell anaemia.匹多酸镁联合羟基脲治疗镰状细胞贫血患儿的I期研究。
Br J Haematol. 2008 Jan;140(1):80-5. doi: 10.1111/j.1365-2141.2007.06884.x. Epub 2007 Nov 7.
5
Soluble CD163 levels in children with sickle cell disease.镰状细胞病患儿可溶性 CD163 水平。
Br J Haematol. 2011 Apr;153(1):105-10. doi: 10.1111/j.1365-2141.2011.08580.x. Epub 2011 Feb 20.
6
Dactylitis in a child with sickle cell trait.患有镰状细胞性状的儿童的手指炎。
Can Med Assoc J. 1985 Apr 1;132(7):814-5.
7
Hydroxycarbamide and erythropoietin in the preoperative management of children with sickle cell anaemia undergoing moderate risk surgery.羟基脲和促红细胞生成素在中度风险手术的镰状细胞贫血患儿术前管理中的应用
Br J Haematol. 2009 Feb;144(3):453-4. doi: 10.1111/j.1365-2141.2008.07463.x. Epub 2008 Nov 17.
8
Acute splenic sequestration in female children with sickle cell disease in the North of Jordan.约旦北部患有镰状细胞病女童的急性脾滞留
J Trop Pediatr. 2006 Dec;52(6):416-20. doi: 10.1093/tropej/fml042. Epub 2006 Sep 2.
9
Genetic Blood Disorders Survey in the Sultanate of Oman.阿曼苏丹国的遗传性血液疾病调查。
J Trop Pediatr. 2003 Jul;49 Suppl 1:i1-20.
10
Prediction of adverse outcomes in children with sickle cell disease.镰状细胞病患儿不良结局的预测
N Engl J Med. 2000 Jan 13;342(2):83-9. doi: 10.1056/NEJM200001133420203.

引用本文的文献

1
Interventions for chronic kidney disease in people with sickle cell disease.镰状细胞病患者慢性肾脏病的干预措施。
Cochrane Database Syst Rev. 2023 Aug 4;8(8):CD012380. doi: 10.1002/14651858.CD012380.pub3.
2
Hydroxyurea (hydroxycarbamide) for sickle cell disease.羟基脲（羟脲）治疗镰状细胞病。
Cochrane Database Syst Rev. 2022 Sep 1;9(9):CD002202. doi: 10.1002/14651858.CD002202.pub3.
3
Interventions for preventing silent cerebral infarcts in people with sickle cell disease.镰状细胞病患者无症状性脑梗死的预防干预措施。
Cochrane Database Syst Rev. 2020 Apr 6;4(4):CD012389. doi: 10.1002/14651858.CD012389.pub3.
4
Interventions for chronic kidney disease in people with sickle cell disease.镰状细胞病患者慢性肾脏病的干预措施。
Cochrane Database Syst Rev. 2017 Jul 3;7(7):CD012380. doi: 10.1002/14651858.CD012380.pub2.
5
Evidence review of hydroxyurea for the prevention of sickle cell complications in low-income countries.羟脲预防低收入国家镰状细胞并发症的证据回顾。
Arch Dis Child. 2013 Nov;98(11):908-14. doi: 10.1136/archdischild-2012-302387. Epub 2013 Aug 30.